Casey Statement on First Set of Lower, Medicare-Negotiated Prescription Drug Prices
August 15, 2024
August 15, 2024
WASHINGTON, Aug. 15 -- Sen. Robert Casey Jr., D-Pennsylvania, issued the following news release:
Statement follows announcement of the new, lower costs of the first ten prescription drugs subject to Medicare price negotiations
Casey fought to pass law giving Medicare the power to negotiate and lower prescription drug prices
New, lower prices will go into effect for Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and Novo . . .
Statement follows announcement of the new, lower costs of the first ten prescription drugs subject to Medicare price negotiations
Casey fought to pass law giving Medicare the power to negotiate and lower prescription drug prices
New, lower prices will go into effect for Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and Novo . . .